News & Insights

Markets
CASI

CASI Pharmaceuticals, Inc. Q2 Loss Widens

August 11, 2023 — 07:26 am EDT

Written by RTTNews.com for RTTNews ->

(RTTNews) - CASI Pharmaceuticals, Inc. (CASI) announced Loss for its second quarter that increased from last year

The company's earnings came in at -$10.24 million, or -$0.77 per share. This compares with -$7.68 million, or -$0.56 per share, in last year's second quarter.

The company's revenue for the quarter rose 14.6% to $9.82 million from $8.57 million last year.

CASI Pharmaceuticals, Inc. earnings at a glance (GAAP) :

-Earnings (Q2): -$10.24 Mln. vs. -$7.68 Mln. last year. -EPS (Q2): -$0.77 vs. -$0.56 last year. -Revenue (Q2): $9.82 Mln vs. $8.57 Mln last year.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

Markets
RTTNews
Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.
More articles by this source ->

Stocks mentioned

CASI

More Related Articles

Info icon

This data feed is not available at this time.

  • •

Sign up for Smart Investing to get the latest news, strategies and tips to help you invest smarter.